Has Ryan Frankel, MD received payments from drug or device companies?

Yes. Drug and device makers reported $10,972 in general payments to Ryan Frankel, MD across 461 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ryan Frankel, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ryan Frankel, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ryan Frankel, MD

Urology · North Easton, MANPI 1992972574

Payments from drug & device makers

$10,972in general payments, 2019–2025

Across 461 payments — averaging $23.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Astellas Pharma US Inc$1K
Antares Pharma, Inc.$732
Endo Pharmaceuticals Inc.$548
Teleflex LLC$511
Pfizer$491
Ferring Pharmaceuticals Inc.$483
plus $7K from 53 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Astellas Pharma US Inc	71	$1,312
Antares Pharma, Inc.	27	$732
Endo Pharmaceuticals Inc.	27	$548
Teleflex LLC	20	$511
Pfizer	23	$491
Ferring Pharmaceuticals Inc.	16	$483
AbbVie(2 entities)	17	$483
Sumitomo Pharma America, Inc.	18	$402
Tolmar, Inc.	20	$400
Johnson & Johnson(2 entities)	14	$376
Dentsply IH AB	13	$359
Urogen Pharma, Inc.	10	$315
Dendreon Pharmaceuticals LLC	13	$278
Myriad Genetic Laboratories, Inc.	17	$270
Boston Scientific	9	$269
Endo USA, Inc.	9	$259
180 Medical, Inc.	9	$236
Neotract Inc.	7	$235
Coloplast	10	$230
Progenics Pharmaceuticals, Inc.	9	$230
Accord Healthcare, Inc.	8	$189
Urovant Sciences Inc	8	$185
Immunitybio, Inc.	8	$184
Bioprotect Medical, Inc.	4	$163
Procept Biorobotics Corporation	2	$152
Histosonics, Inc.	1	$149
Acerus Pharmaceuticals Corporation	8	$144
Convatec Inc.	3	$97
Laborie Medical Technologies Corp.	3	$96
Merck	3	$91
C. R. Bard, Inc. & Subsidiaries	4	$89
Blue Earth Diagnostics	4	$83
Myovant Sciences Inc.	4	$79
Tolmar Pharmaceuticals, Inc.	4	$79
Hollister Incorporated	3	$69
Kowa Pharmaceuticals America, Inc.	4	$61
Axonics, Inc.	3	$55
ABC Home Medical Supply, Inc.	2	$50
Janssen Scientific Affairs, LLC	1	$47
Telix Pharmaceuticals	2	$43
Healthtronics Stone Solutions, LLC	1	$41
Mission Pharmacal Company	2	$41
Valencia Technologies Corporation	2	$33
Bayer	1	$32
Sun Pharmaceutical Industries Inc.	2	$31
Sanofi	2	$28
Caris MPI, Inc.	1	$25
Agiliti Surgical, Inc.	1	$25
Otsuka America Pharmaceutical, Inc.	1	$24
E.r. Squibb & Sons, L.L.C.	1	$21
Palette Life Sciences, Inc.	1	$21
Novartis	1	$21
Medtronic	1	$19
Therapeuticsmd, Inc.	1	$17
Dentsply IH Inc.	1	$17
Alnylam Pharmaceuticals Inc.	1	$15
Calyxo, Inc.	1	$15
Olympus America Inc.	1	$13
Hologic Sales And Service, LLC	1	$12

How this compares

$10,972 in reported general payments places this provider in the 80th percentile of 327 urology providers in Massachusetts.

See all urology providers in Massachusetts →

Medicare billing

Part B allowed, 2024

$418,570

Medicare patients

786

Services billed

9,532

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other urology in North Easton

James FitzgeraldNorth Easton$16K
Padraic McCahillNorth Easton$12K
Natalya LopushnyanNorth Easton$12K
Christopher CutieBoston$3.5M
Henry MitchesonWatertown$1.6M
Brian EisnerBoston$1.4M
Mark PrestonBoston$1.2M
David StaskinBrighton$807K
Abraham MorgentalerChestnut Hill$522K
Alejandro SanchezBoston$349K

See the full list for Massachusetts →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →